Thermotherapy and thermoablation for benign prostatic hyperplasia

Area of Science:

• Urology
• Minimally Invasive Surgery
• Thermotherapy

Background:

• Benign prostatic hyperplasia (BPH) is a common condition requiring effective treatment.
• Transurethral microwave thermotherapy (TUMT) is a standard minimally invasive option for symptomatic BPH.

Purpose of the Study:

• To review current literature on transurethral microwave thermotherapy (TUMT) for benign prostatic hyperplasia (BPH).
• To provide up-to-date information on TUMT efficacy, durability, and cost-effectiveness.

Main Methods:

• Review of recent studies on transurethral microwave thermotherapy (TUMT).
• Analysis of outcomes, morbidity, and cost-effectiveness compared to other BPH treatments.
• Evaluation of long-term durability and retreatment rates.

Main Results:

• High-energy TUMT programs show superior outcomes compared to standard protocols.
• Intraprostatic temperature monitoring may enhance clinical results through treatment individualization.
• TUMT demonstrates durable improvement for over 2.5 years, with outcomes comparable to transurethral resection of the prostate (TURP).
• TUMT has lower retreatment rates and is more cost-effective than medical management for BPH.

Conclusions:

• Innovations in high-energy TUMT improve clinical outcomes and reduce morbidity, solidifying its role in BPH management.
• Further research into therapeutic protocols, monitoring, and selection criteria can optimize TUMT.
• TUMT is a cost-efficient and durable treatment option for benign prostatic hyperplasia.